- Home
- BTAI vs NDLS Comparison
BTAI vs NDLS Comparison
Compare BTAI & NDLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | BTAI | NDLS |
|---|---|---|
| Founded | 2017 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 49.2M | 29.8M |
| IPO Year | 2018 | 2013 |
Fundamental Metrics
Financial Performance| Metric | BTAI | NDLS |
|---|---|---|
| Price | $2.04 | $0.73 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 5 | 1 |
| Target Price | ★ $32.80 | N/A |
| AVG Volume (30 Days) | 578.0K | ★ 626.7K |
| Earning Date | 11-12-2025 | 11-05-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $752,000.00 | ★ $494,087,000.00 |
| Revenue This Year | N/A | $2.18 |
| Revenue Next Year | $416.40 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.17 | $0.55 |
| 52 Week High | $9.26 | $1.74 |
Technical Indicators
Market Signals| Indicator | BTAI | NDLS |
|---|---|---|
| Relative Strength Index (RSI) | 48.39 | 47.91 |
| Support Level | $1.82 | $0.76 |
| Resistance Level | $2.30 | $1.08 |
| Average True Range (ATR) | 0.18 | 0.10 |
| MACD | 0.03 | -0.00 |
| Stochastic Oscillator | 37.30 | 31.37 |
Price Performance
Historical ComparisonAbout BTAI BioXcel Therapeutics Inc.
BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.
About NDLS Noodles & Company
Noodles & Co is a restaurant concept offering lunch and dinner within the fast-casual segment of the restaurant industry. The company's menu includes a variety of cooked-to-order dishes, including noodles and pasta, soups, salads and appetizers. The company also provides dining, pick-up and delivery services.